Seneca Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Seneca Therapeutics, Inc. — Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherap...
Companies similar to Seneca Therapeutics, Inc.
Epsilogen Ltd
Harnessing the power of IgE
United Kingdom
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to c...
Pittsburgh, United States
Grit Biotechnology
Developing novel cell therapies to transform the lives of people with cancer.
China
Rival Readout
Competing with Seneca Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Hercules Pharmaceuticals
Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid...
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
OncoMyx Therapeutics
We are developing myxoma virotherapies to expand the effectiveness of immunotherapies in t...
Phoenix, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Precision Biologics, Inc.
Precision Biologics, Inc. has a cancer immunotherapy platform with 2 unique clinical stage...
Bethesda, United States
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Houston, United States
About Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. is pioneering advancements within the Biopharma and Biotechnology sectors, with a focus on developing a novel, oncolytic immunotherapeutic for patients afflicted with solid cancers. The company, established in 2018, is headquartered in the United States and has been strategically formed by Dr.
Development of oncolytic immunotherapeutic candidates, Advanced targeted cancer treatments, Clinical trials for cancer therapies, Biomarker research
Oncology Researchers, Healthcare Providers, Cancer Patients, Academic Institutions
Oncolytic Immunotherapy, Seneca Valley Virus, SVV-001, Solid Tumor Treatment, TEM8 Receptor Targeting, Cancer Therapy, Clinical Trials, Phase I/II Clinical Trials, Cancer Vaccines, Gene Therapy, Breast Cancer, Lung Cancer, Neuroendocrine Tumors
B2B, Platform, White Label
Licensing, Product Sales, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Seneca Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Seneca Therapeutics, Inc. on 7 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
